Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Davies MJ, DAlessio DA, Fradkin J et al (2018) Management of hyperglycemia in type 2 diabetes, 2018
Who should/should not take L-Carnitine
Keating NL, O'Malley AJ, Smith MR
The Phase 1 MAD study of oral VK2735 is an extension of the companys Phase 1 single ascending dose (SAD)/MAD trial of VK2735 administered subcutaneously mentioned above
Presented for research literature review only Guzmn-Guilln R et al
Transmembrane domains in N- and C- terminal regions, as well as organelle-specific target molecules are the primary determinants in target localization of APXs (Ishikawa et al., 1998
US$ 26.85
US$ 22.60
US$ 20.89
US$ 20.82
